Autism research is moving fast across several fronts, from genetics and brain imaging to new diagnostic tools and updated prevalence numbers. The most striking recent data point: as of 2022, the CDC reports that 1 in 31 eight-year-olds in the United States has been identified with autism spectrum disorder, a continued rise from previous surveillance years. Here’s what researchers are finding and what it means.
Prevalence Is Still Climbing, and the Demographics Are Shifting
The CDC’s most recent surveillance data, covering 16 sites across the U.S. in 2022, puts autism prevalence at 32.2 per 1,000 children aged 8. That’s up from earlier estimates and varies widely by location, from 9.7 per 1,000 in Laredo, Texas to 53.1 per 1,000 in parts of California. Boys are diagnosed 3.4 times as often as girls, though that ratio has been narrowing. It was 4.2 in 2018, dropped to 3.8 in 2020, and is now 3.4. More girls are being identified, likely reflecting better awareness of how autism presents differently across sexes.
A significant demographic shift has also emerged. For years, white children had the highest autism prevalence in CDC data. That’s no longer the case. Asian or Pacific Islander children now have the highest prevalence at 38.2 per 1,000, followed by American Indian or Alaska Native (37.5), Black (36.6), Hispanic (33.0), and multiracial children (31.9). White children have the lowest prevalence at 27.7. This pattern, first observed in 2020, likely reflects improved screening access in communities that were historically underdiagnosed rather than a true change in who develops autism.
Genetics: Many Genes, One Pattern
Autism is genetically complex. There’s no single “autism gene.” Instead, researchers have identified a growing list of high-confidence risk genes, each contributing a small piece to the overall picture. Recent work has focused on understanding what these genes actually do in the brain, and the findings suggest they converge on a shared set of problems.
A study published in Genome Research tested nine high-confidence autism risk genes by silencing them one at a time in lab-grown neurons. These genes all regulate how other genes get turned on and off, essentially acting as control switches for brain cell development. When researchers knocked each one down individually, the resulting disruptions in gene activity and neuron firing overlapped significantly. In other words, different genetic starting points led to similar downstream effects on how brain cells communicate. This convergence helps explain why autism, despite having hundreds of possible genetic contributors, produces a recognizable set of traits. It also opens the door to interventions that target shared biological pathways rather than needing a unique fix for each gene variant.
Brain Connectivity Looks Different
Brain imaging research continues to refine the picture of how neural wiring differs in autistic people. The emerging pattern is not simply “more” or “less” connectivity but a specific combination of both. In autistic brains, nearby regions tend to be more strongly connected to each other (local overconnectivity), while distant regions that need to coordinate for complex tasks are less connected (long-distance underconnectivity).
A recent study using functional MRI found reduced connectivity between the frontal pole, a region involved in planning and decision-making, and parts of the temporal lobe that process faces. At the same time, connections between the cerebellum and visual processing areas were stronger than typical. Reduced connectivity between the amygdala and areas involved in face recognition has also been linked to difficulties with social cognition. These findings are helping researchers understand the biological basis of specific autism traits, like why social cues can be harder to read while sensory details might be processed with unusual intensity.
Prenatal Immune Activation Leaves a Lasting Mark
One of the more compelling lines of research involves the mother’s immune system during pregnancy. When the immune system activates strongly during gestation, whether from infection or inflammation, it can alter fetal brain development in ways that persist long after birth.
A 2025 study in Molecular Psychiatry provided the first evidence in primates that a temporary immune response during pregnancy causes lasting changes in gene activity within the offspring’s amygdala, a brain region central to emotional and social processing. Specifically, the brain’s resident immune cells (microglia) showed reduced activity in signaling pathways critical for synaptic pruning, the process by which the developing brain eliminates unnecessary connections to fine-tune its circuits. When this pruning process is disrupted, it can affect how neural circuits stabilize and how the brain processes social and emotional information. This doesn’t mean every prenatal infection leads to autism, but it clarifies one biological mechanism through which environmental factors during pregnancy could shift neurodevelopmental trajectories.
Eye-Tracking as an Early Diagnostic Tool
One of the biggest practical challenges in autism has always been the gap between when signs first appear and when a child gets a formal diagnosis. Current guidelines from the American Academy of Pediatrics recommend autism-specific screening at 18 and 24 months during routine well-child visits, typically using parent-completed questionnaires like the Modified Checklist for Autism in Toddlers (M-CHAT). These tools work, but they depend on parent observation and can miss subtler presentations.
A study in JAMA Network Open tested whether eye-tracking technology could improve early detection in primary care settings. Researchers measured how children directed their gaze at social scenes, then combined that data with the pediatrician’s clinical impression. The eye-tracking biomarker alone had 78% sensitivity and 77% specificity, meaning it correctly identified most children with autism while keeping false positives manageable. When combined with the pediatrician’s diagnosis and their level of diagnostic certainty, accuracy jumped to 91% sensitivity and 87% specificity. Out of 127 cases, 114 matched the gold-standard reference diagnosis. This kind of objective, tech-assisted screening could help catch cases earlier, particularly in communities with limited access to developmental specialists.
The Gut-Brain Connection: Promising but Unproven
The idea that gut bacteria influence autism symptoms has generated enormous public interest. Gastrointestinal problems are common in autistic people, and the gut microbiome communicates with the brain through immune and hormonal pathways. This has led to clinical trials testing whether probiotics can improve core autism symptoms.
A systematic review and meta-analysis published in 2024 pooled data from 12 randomized controlled trials involving 630 participants. Probiotics showed a small, borderline-significant effect on core autism symptoms, with parallel-group trials (where one group gets probiotics and another gets a placebo) showing a slightly stronger positive signal. However, the researchers concluded that the available evidence does not yet support high-quality recommendations for using probiotics to treat autism symptoms. The effect sizes are small, the studies are heterogeneous, and it’s not clear which strains, doses, or durations might matter. The gut-brain axis remains a legitimate area of investigation, but it’s not ready for clinical application.
Virtual Reality for Social Skills
Virtual reality is being tested as a way to practice social interactions in a controlled, repeatable environment. A systematic review of VR interventions found positive effects on social skills in autistic children and adolescents, but the benefits varied depending on the individual’s support needs. Children with fewer support needs benefited more, particularly from immersive VR environments that simulated complex social scenarios like job interviews, group conversations, or reading body language in real time. Children with higher support needs showed progress mainly in basic skills, and simpler, non-immersive VR setups (think screen-based programs rather than headsets) were more practical and effective for this group. The lower cost and flexibility of non-immersive options also make them more scalable.
Co-occurring Conditions in Autistic Adults
Research increasingly recognizes that autism rarely exists in isolation. More than 95% of autistic people have at least one additional condition. The most common include ADHD, anxiety disorders, depression, sleep problems, gastrointestinal issues, and epilepsy. Sensory processing difficulties, eating challenges, and obsessive-compulsive symptoms are also frequent. In adolescents and adults, depression and anxiety become particularly prevalent, and large mood swings or intense emotional reactions are commonly reported.
This high rate of co-occurring conditions has real consequences for quality of life and longevity. Autistic adults face elevated risks for a range of physical and mental health problems, and these needs are often under-recognized in healthcare settings. The research increasingly emphasizes that effective care for autistic people requires identifying and treating these co-occurring conditions individually rather than attributing every symptom to autism itself.
Naturalistic Therapies Gain Ground
On the intervention side, a growing body of evidence supports naturalistic developmental behavioral interventions, or NDBIs. These approaches embed skill-building into everyday activities and play rather than relying on structured, repetitive drills. Traditional approaches like discrete trial training have long been criticized for producing skills that don’t transfer well to real-world situations, with children becoming overly dependent on prompts and struggling with spontaneous responses.
A network meta-analysis of 41 studies involving 2,781 participants compared six different NDBI methods across five outcome areas: receptive language, expressive language, cognitive development, social skills, and reduction of autism-related symptoms. The analysis confirmed that NDBIs as a category are effective, but also highlighted that different specific approaches may have different strengths. Some showed stronger results for language development, others for social skills. This kind of head-to-head comparison is relatively new. Earlier research mostly compared NDBIs as a group against non-NDBI approaches, leaving families and clinicians without guidance on which specific method might best fit a particular child’s profile.